Scientists have uncovered evidence suggesting that the metastatic spread of cancer is not a random process but rather adheres to a predictable biological program. By meticulously analyzing colon tumor cells, they successfully identified specific gene expression patterns indicative of a cancer’s propensity to metastasize. Their innovative artificial intelligence model, named MangroveGS, demonstrates remarkable predictive power, achieving approximately 80% accuracy in assessing this metastatic risk. Notably, its efficacy extends across a diverse range of cancer types. This groundbreaking development holds the potential to revolutionize clinical decision-making, guiding oncologists in determining which patients require intensive, aggressive treatments and which may benefit from less invasive approaches.

